{
  "id": "clinical#screening_cues_1b9828f5",
  "content": "behavioural and neurodevelopmental disorders in clinical settings), working groups collated\ndiagnostic information using a standardized template (referred to as a “content form”), with\nrelevant references. This information served as source material for the development of the\nCDDR, with the final editorial responsibility vested in the WHO Department of Mental Health\nand Substance Use. The brief descriptions in the MMS and the more detailed essential features\nin the CDDR were developed together in order to be fully compatible, though designed for\ndifferent purposes. The MMS brief descriptions are typically summaries of the essential features\nfor the corresponding entity in the CDDR, although these brief descriptions alone do not provide\nsufficient information for implementation in clinical settings.\nPublic review and field testing\nProposals developed by working groups were described in the scientific literature (e.g. 20–26),\nmade available for public review (27), and tested via a systematic programme of global field\nstudies (see the section on field studies below). Scientific oversight for the field studies was\nprovided by the ICD-11 Field Studies Coordination Group (FSCG) (28), comprising global\nleaders in clinical care, scientific research and public health representing all WHO regions, with",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues behavioural and neurodevelopmental disorders in clinical settings), working groups collated\ndiagnostic information using a standardized template (referred to as a “content form”), with\nrelevant references. This information served as source material for the development of the\nCDDR, with the final editorial responsibility vested in the WHO Department of Mental Health\nand Substance Use. The brief descriptions in the MMS and the more detailed essential features\nin the CDDR were developed together in order to be fully compatible, though designed for\ndifferent purposes. The MMS brief descriptions are typically summaries of the essential features\nfor the corresponding entity in the CDDR, although these brief descriptions alone do not provide\nsufficient information for implementation in clinical settings.\nPublic review and field testing\nProposals developed by working groups were described in the scientific literature (e.g. 20–26),\nmade available for public review (27), and tested via a systematic programme of global field\nstudies (see the section on field studies below). Scientific oversight for the field studies was\nprovided by the ICD-11 Field Studies Coordination Group (FSCG) (28), comprising global\nleaders in clinical care, scientific research and public health representing all WHO regions, with Behavioural and neurodevelopmental disorders in clinical settings), working groups collated\ndiagnostic information using a standardized template (referred to as a “content form”), with\nrelevant references. this informati..."
}